<h2 id="history">History</h2>

<p>
Apollo Life Sciences GmbH was founded in December 2019 as a spin-out of QIAGEN GmbH, with 14 former QIAGEN employees from the Research & Foundation department.
Apollo Life Sciences is continually growing its team of scientists, engineers and infromaticians developing its its flagship patent-filed technology, <b>genexyz</b>.
After four years of development, <b>genexyz</b> will be launched as an instrument and consumables platform in October 2020.
</p>

